CRI

Value Q1, 25Q2, 25 TTM Total revenue 681.11 M615.49 M 2.98 B Gross profit 293.87 M412.6 M 1.45 B Operating expenses 268.49 M279.89 M 1.22 B Selling/general/admin expenses 270.05 M276.13 M 1.18 B Research & development —— — Operating income 28.44 M139.83 M 282.06 M Non-Operating Income, Total 3.58 M8.87 M 11.1 M Interest expense, net of interest capitalized 11.76 M11.31 M 30.7 M Non-Operating Income, excl. Interest Expenses -8.1 M-2.09 M -19.1 M Unusual income/expense -86 K-352 K -500 K Pretax income 19.86 M136.65 M 247.28 M Equity in earnings —— — Taxes 5.52 M31.69 M 52.18 M Non-controlling/minority interest —— — After tax other income/expense 547 K— — Net income before discontinued operations 14.34 M104.96 M 195.1 M Discontinued operations —— — Net income 14.34 M104.96 M 195.1 M Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 13.94 M102.11 M 190.08 M Basic earnings per share (Basic EPS) 0.392.87 5.35 Diluted earnings per share (Diluted EPS) 0.392.87 5.35 Average basic shares outstanding 35.49 M35.59 M — Diluted shares outstanding 35.5 M35.6 M — EBITDA 422.17 M144.79 M 1.19 B EBIT 409.48 M132.71 M 1.14 B Cost of revenue 3.14 M202.89 M 618.73 M Other cost of goods sold 3.14 M-410 K 1.28 M Depreciation & amortization (cash flow) 12.68 M12.08 M 51.34 M